ID
22319
Beschreibung
Study ID: 100151 Clinical Study ID: EGF100151 Study Title: A Phase III, Randomized, Open-label, Multicenter Study Comparing GW572016 and Capecitabine (XELODA) versus Capecitabine in Women with Refractory Advanced or Metastatic Breast Cancer Clinicaltrials.gov Identifier: NCT00078572 https://clinicaltrials.gov/ct2/show/NCT00078572 Procedure: Disease History Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tyverb,Tykerb,Tycerb Study Indication: Breast Cancer; Neoplasms, Breast
Link
https://clinicaltrials.gov/ct2/show/NCT00078572
Stichworte
Versionen (1)
- 29.05.17 29.05.17 -
Hochgeladen am
29. Mai 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Disease History NCT00078572
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Disease History NCT00078572
Beschreibung
Prior Anti-Cancer Surgery Screening
Alias
- UMLS CUI-1
- C0543467
- UMLS CUI-2
- C0920425
Beschreibung
received surgery for the cancer
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C0920425
Beschreibung
If YES, record in chronological order below:
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0543467
Beschreibung
Procedure
Datentyp
text
Alias
- UMLS CUI [1]
- C0184661
Beschreibung
Prior Anti-Cancer Systemic Therapy Screening
Alias
- UMLS CUI-1
- C1515119
- UMLS CUI-2
- C0920425
Beschreibung
prior anti-cancer systemic therapy for the cancer
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1515119
- UMLS CUI [1,2]
- C0920425
Beschreibung
If NO, leave remainder of page blank. If YES, record, in chronological order, all prior therapies for the cancer under study.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0040808
- UMLS CUI [1,2]
- C0237753
Beschreibung
Therapy
Datentyp
text
Alias
- UMLS CUI [1]
- C1515119
Beschreibung
Intent
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1283828
- UMLS CUI [1,2]
- C1515119
Beschreibung
No. of cycles
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1515119
- UMLS CUI [1,2]
- C0750480
Beschreibung
Total cumulative dose of Anthracycline
Datentyp
float
Maßeinheiten
- mg/m2
Alias
- UMLS CUI [1,1]
- C0003234
- UMLS CUI [1,2]
- C3174092
- UMLS CUI [2]
- C1515119
Beschreibung
Date started
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1515119
Beschreibung
Date stopped
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C1515119
Beschreibung
Best response
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2986560
- UMLS CUI [1,2]
- C1515119
Beschreibung
Date of progression
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0242656
- UMLS CUI [1,3]
- C1515119
Beschreibung
Prior Anti-Cancer Radiotherapy Screening
Alias
- UMLS CUI-1
- C1522449
- UMLS CUI-2
- C0920425
Beschreibung
prior radiotherapy for the cancer
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0920425
Beschreibung
If YES, record in chronological order below.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1515974
- UMLS CUI [1,2]
- C1522449
Beschreibung
Date started
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1522449
Beschreibung
Date stopped
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0806020
- UMLS CUI [1,2]
- C1522449
Beschreibung
Estimated total dose amount
Datentyp
float
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C1265611
Beschreibung
Estimated total dose units
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C1519795
Beschreibung
Best response
Datentyp
text
Alias
- UMLS CUI [1,1]
- C2986560
- UMLS CUI [1,2]
- C1522449
Ähnliche Modelle
XELODA and Lapatinib Advanced or Metastatic Breast Cancer Disease History NCT00078572
C1710477 (UMLS CUI-2)
C0678222 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0678222 (UMLS CUI [1,2])
C1719707 (UMLS CUI [1,2])
C3172269 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0036525 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2])
C0678222 (UMLS CUI [2])
C0920425 (UMLS CUI-2)
C0920425 (UMLS CUI [1,2])
C0543467 (UMLS CUI [1,2])
C0920425 (UMLS CUI-2)
C0920425 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0750480 (UMLS CUI [1,2])
C3174092 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2])
C1515119 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,2])
C1515119 (UMLS CUI [1,3])
C0920425 (UMLS CUI-2)
C0920425 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,2])
C1519795 (UMLS CUI [1,3])
Keine Kommentare